NetScientific plc - ProAxsis Announces Sales Acceleration of its CE Marked Active
FTSE 250, industry-leading device & formulation business for inhaled airways disease
Our senior team has worked together for many years, delivering high-level strategic healthcare consultancy with seamless execution and unrivalled market intelligence.
Consilium Healthcare - RT @MelanomaBlog: Simon Stevens the CEO of @NHSEngland says "The top issues for the NHS in Cancer care over the next 5 years. #Early Diagno…